Expression, Purification, and Characterization of a Functional Mutant Recombinant Human Interleukin-2

被引:8
作者
Liu, Mingjun [1 ]
Wang, Bin [2 ]
Sun, Guirong [1 ]
Qian, Dongmeng [2 ]
Yan, Zhiyong [2 ]
Song, Xuxia [2 ]
Ding, Shouyi [2 ]
机构
[1] Med Coll Qingdao Univ, Affiliated Hosp, Clin Immunol Lab, Qingdao 266003, Peoples R China
[2] Qingdao Univ Med Coll, Key Lab Med & Biotechnol, Qingdao 266021, Peoples R China
关键词
Biological activity; chromatography; expression; interleukin-2; mutant; purification; soluble form; ESCHERICHIA-COLI; CELLS; IDENTIFICATION; DOMAIN; IL-2; CDNA;
D O I
10.2174/092986610792231474
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the current study, a mutant recombinant human interleukin-2 (MhIL-2) was generated using site-directed mutagenesis. The bacteria transformed with plasmid pET15b-MhIL-2 were cultured in LB medium containing 0.6mM IPTG for 8 hours at 27 degrees C. Approximately 90% of His-MhIL-2 was efficiently expressed in soluble form. Purification efficiency was optimized using a number of strategies, including nickel ion chelating chromatography, desalting chromatography, thrombin cleavage and Superdex 75 gel filtration chromatography. The final product had >95% purity. PBMCs, CD4+ and CD8+ T cell proliferation assays revealed that one such mutant has identical functional property to the wildtype hIL-2. In summary, we generated a mutant hIL-2 that is functionally identical to wild-type hIL-2.
引用
收藏
页码:1280 / 1284
页数:5
相关论文
共 17 条
[1]  
BHARAT H, 2005, PROTEIN EXPRES PURIF, V39, P189
[2]   REENGINEERING THE POLYMERASE DOMAIN OF KLENOW FRAGMENT AND EVALUATION OF OVERPRODUCTION AND PURIFICATION STRATEGIES [J].
DERBYSHIRE, V ;
ASTATKE, M ;
JOYCE, CM .
NUCLEIC ACIDS RESEARCH, 1993, 21 (23) :5439-5448
[3]   Overview of interleukin-2 function, production and clinical applications [J].
Gaffen, SL ;
Liu, KD .
CYTOKINE, 2004, 28 (03) :109-123
[4]  
JU G, 1987, J BIOL CHEM, V262, P5723
[5]   Isolation and characterization of modified species of a mutated (Cys125-Ala) recombinant human interleukin-2 [J].
Moya, G ;
González, LJ ;
Huerta, V ;
García, Y ;
Morera, V ;
Pérez, D ;
Breña, F ;
Araña, M .
JOURNAL OF CHROMATOGRAPHY A, 2002, 971 (1-2) :129-142
[6]   EXPRESSION OF AMPLIFIED CDNA AND GENOMIC SEQUENCES ENCODING HUMAN INTERLEUKIN-2 IN CHINESE-HAMSTER OVARY CELLS [J].
ONOMICHI, K ;
ETO, Y ;
SHIBAI, H .
JOURNAL OF BIOCHEMISTRY, 1987, 102 (01) :123-131
[7]  
PAN H, 1991, J BIOL CHEM, V266, P11347
[8]   NEW APPROACHES FOR THE HIGH-LEVEL EXPRESSION OF HUMAN INTERLEUKIN-2 CDNA IN ESCHERICHIA-COLI [J].
SATO, T ;
MATSUI, H ;
SHIBAHARA, S ;
KOBAYASHI, T ;
MORINAGA, Y ;
KASHIMA, N ;
YAMASAKI, S ;
HAMURO, J ;
TANIGUCHI, T .
JOURNAL OF BIOCHEMISTRY, 1987, 101 (02) :525-534
[9]   GENE FOR T-CELL GROWTH-FACTOR - LOCATION ON HUMAN CHROMOSOME-4Q AND FELINE CHROMOSOME-B1 [J].
SEIGEL, LJ .
SCIENCE, 1984, 223 (4632) :175-178
[10]   Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization [J].
Setoguchi, R ;
Hori, S ;
Takahashi, T ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :723-735